[The use of endolymphatic chemotherapy in patients with metastatic stomach cancer].
The results of the endolymphatic chemotherapy application in patients with metastatic cancer of stomach are presented. The low toxicity and high effectiveness were suggested. One-year survival was achieved in 42.2% of patients.